Skip to main content
SpringerLink
Log in

AIDS-Associated Burkitt’s Lymphoma

  • Chapter
  • First Online:
Burkitt’s Lymphoma

Part of the book series: Current Cancer Research ((CUCR))

Abstract

Today AIDS-associated Burkitt’s lymphoma (BL) and atypical BL remain a significant cause of morbidity and mortality in HIV-infected patients the world over and especially in sub-Saharan Africa. While the overall incidence of BL appears to be stable in the backdrop of HIV infection in the current antiretroviral therapeutic era, there is clearly a trimodal age peak that is now observed and is clearly reflective of AIDS association, a predominance of males persists, and improved understanding of pathogenic mechanisms may shed new light on the disease process especially in HIV-infected patients. Importantly, it is clinically well recognized that it is no longer appropriate to consider AIDS-related non-Hodgkin’s lymphoma as a single disease entity and rather treatment of AIDS lymphoma needs to be tailored to lymphoma subtype. While intensive therapeutic strategies in the western world are clearly improving outcome, in AIDS epicenters of the world and especially sub-Saharan Africa more pragmatic and risk-adapted approaches are clearly needed. We are also likely entering the era of viral-targeted therapeutic approaches that may be impactful in resource-challenged areas of the world and provide new strategies for disease prevention altogether.

Peter M. Mwamba and Scot C. Remick were supported in part by NIH grant nos.: D43 CA153707.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, and Vardiman JW (2008). WHO classification of tumours of haematolpoietic and lymphoid tissues. In: WHO classification of tumours, vol. 2, 4th edn. IARC Press, Lyon

    Google Scholar 

  2. Centers for Disease Control (1981) Pneumocystis pneumonia—Los Angeles. MMWR Morb Mortal Wkly Rep 30:250–252

    Google Scholar 

  3. Centers for Disease Control (1981) Kaposi’s sarcoma and pneumocystis Pneumonia among homosexual men—New York City and California. MMWR Morb Mortal Wkly Rep 30:305–308

    Google Scholar 

  4. Centers for Disease Control (1982) Diffuse and undifferentiated non-Hodgkin’s lymphoma Kaposi’s sarcoma and pneumocystis pneumonia among homosexual men—New York City and California. MMWR Morb Mortal Wkly Rep 30:305–308

    Google Scholar 

  5. Doll DC, List AF (1982) Burkitt’s lymphoma in a homosexual. Lancet 1:1026–1027

    Article  PubMed  CAS  Google Scholar 

  6. Ziegler JL, Drew WL, Miner RC, Mintz L, Rosenbaum E, Gershow J, Lennette ET, Greenspan J, Shillitoe E, Beckstead J, Casavant C, Yamamato K (1982) Outbreak of Burkitt’s-like lymphoma in homosexual men. Lancet 2:631–633

    Article  PubMed  CAS  Google Scholar 

  7. Centers for Disease Control (1985) Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States. MMWR Morb Mortal Wkly Rep 34:373–375

    Google Scholar 

  8. Mwanda (aka Otieno MW) WO, Banura C, Katongole-Mbidde E, Johnson JL, Ghannoum M, Dowlati A, Renne R, Arts E, Whalen C, Lederman MM, Remick SC (2002) Therapeutic challenges of AIDS-related non-Hodgkin’s lymphoma in the United States and East Africa. J Natl Cancer Inst 94:718–732

    Article  Google Scholar 

  9. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA (2011) Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 103:753–762

    Article  PubMed  Google Scholar 

  10. Achenbach CJ, Cole SR, Kitahata MM, Casper C, Willig JH, Mugavero MJ, Saag MS (2011) Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS 25:691–700

    Article  PubMed  Google Scholar 

  11. Shiels MS, Pfeiffer RM, Hall HI, Li J, Goedert JJ, Morton LM, Hartge P, Engels EA (2011) Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980–2007. JAMA 305:1450–1459

    Article  PubMed  CAS  Google Scholar 

  12. Mbulaiteye SM, Anderson WV, Bhatia K, Rosenberg PS, Linet MS, Devsa SS (2010) Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973–2005. Int J Cancer 126:1732–1739

    PubMed  CAS  Google Scholar 

  13. Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM (2005) Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol 23:8477–8482

    Article  PubMed  Google Scholar 

  14. Bower M, Palmieri C, Dhillon T (2006) AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 19:14–19

    Article  PubMed  Google Scholar 

  15. Bower M, Fisher M, Hill T, Bower M, Fisher M, Hill T, Reeves I, Walsh J, Orkin C, Phillips AN, Bansi L, Gilson R, Easterbrook P, Johnson M, Gazzard B, Leen C, Pillay D, Schwenk A, Anderson J, Porter K, Gompels M, Sabin CA, Steering Committee UKCHIC (2009) CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK. Haematologica 94:875–880

    Article  PubMed  Google Scholar 

  16. Cote TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Geodert JJ, Blattner WA (1997) Non-Hodgkin’s lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 73:645–650

    Article  PubMed  CAS  Google Scholar 

  17. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107:265–276

    Article  PubMed  CAS  Google Scholar 

  18. International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823–1830

    Article  Google Scholar 

  19. Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell JM, Katlama C, Lazzarin A, Skinhøj P, Barton SE, for the EuroSIDA Study Group (2001) Non-Hodgkin’s lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406–3412

    Article  PubMed  CAS  Google Scholar 

  20. Wolf T, Brodt HR, Fichtlscherer S, Mantzsch K, Hoelzer D, Helm EB, Mitrou PS, Chow KU (2005) Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 46:207–215

    Article  PubMed  Google Scholar 

  21. Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS (2000) Evolving characteristics of AIDS-related lymphoma. Blood 96:4084–4090

    PubMed  CAS  Google Scholar 

  22. Lim ST, Karin R, Nathwani BN, Tulpule A, Espina B, Levine AM (2005) AIDS-related Burkitt’s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23:4430–4438

    Article  PubMed  CAS  Google Scholar 

  23. Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Châtelet FP, Katlama C, Charlotte F, Dupont B, Brousse N, Huerre M, Mikol J, Camparo P, Mokhtari K, Tulliez M, Salmon-Céron D, Boué F, Costagliola D, Raphaël M (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339–2344

    Article  PubMed  CAS  Google Scholar 

  24. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW (1993) Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 54:26–36

    Article  PubMed  CAS  Google Scholar 

  25. Ziegler JL, Katongole-Mbidde E (1996) Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 65:200–203

    Article  PubMed  CAS  Google Scholar 

  26. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S (2000) Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer 82:1585–1592

    Article  PubMed  CAS  Google Scholar 

  27. Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulaiteye S, Appelby P, Reeves G, Jaffe H, and the Uganda Kaposi’s Sarcoma Study Group (2001) A case–control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92:622–627

    Article  PubMed  CAS  Google Scholar 

  28. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118:985–990

    Article  PubMed  CAS  Google Scholar 

  29. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991–2006. Int J Cancer 126:1187–1195

    PubMed  CAS  Google Scholar 

  30. Mwanda WO, Remick SC, Whalen C (2001) Adult Burkitt’s lymphoma in patients with and without human immunodeficiency virus infection in Africa. Int J Cancer 92:687–691

    Article  Google Scholar 

  31. Cremer KJ, Spring SB, Gruber J (1990) Role of human immunodeficiency virus type 1 and other viruses in malignancies associated with acquired immunodeficiency disease syndrome. J Natl Cancer Inst 82:1016–1024

    Article  PubMed  CAS  Google Scholar 

  32. Carbone A (2003) Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4:22–29

    Article  PubMed  CAS  Google Scholar 

  33. Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri F, Tirelli U, Dalla-Favera R, Gaidano G (2001) Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immune-deficiency virus-related lymphomas. Blood 97:744–751

    Article  PubMed  CAS  Google Scholar 

  34. Gaidano G, LoCoco F, Ye BH, Shibata D, Levine AM, Knowles DM (1994) Rearrangements of the bcl-6 gene in AIDS-associated non-Hodgkin’s lymphoma: association with diffuse large-cell subtype. Blood 84:397–402

    PubMed  CAS  Google Scholar 

  35. Gaidano G, Dalla-Favera R (1997) Molecular pathogenesis of AIDS-related non-Hodgkin’s lymphoma. Adv Cancer Res 67:113–153

    Article  Google Scholar 

  36. Gaidano G, Carbone A, Dalla-Favera R (1998) Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis. Monogr Natl Cancer Inst 23:95–100

    Article  PubMed  Google Scholar 

  37. Knowles DM (2003) Etiology and pathogenesis of AIDS-related non-Hodgkin’s lymphoma. Hematol Oncol Clin N Am 17:785–820

    Article  Google Scholar 

  38. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R (1988) Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72:667–671

    PubMed  CAS  Google Scholar 

  39. Ambinder RF (2001) Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 37:1209–1216

    Article  PubMed  CAS  Google Scholar 

  40. Martinez-Maza O, Breen EC (2002) B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 14:528–532

    Article  PubMed  CAS  Google Scholar 

  41. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837–7841

    Article  PubMed  CAS  Google Scholar 

  42. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, Guttierez M, Levine P, Magrath I (1991) Patterns of chromosomal breakpoint locations in Burkitt’s lymphoma: relevance to geography and Epstein-Barr virus association. Blood 77:1516–1526

    PubMed  CAS  Google Scholar 

  43. Muller JR, Janz S, Goedert JJ, Potter M, Rabkin CS (1995) Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sci USA 92:6577–6581

    Article  PubMed  CAS  Google Scholar 

  44. Epeldegui M, Breen EC, Hung YP, Boscardin WJ, Detels R, Martínez-Maza O (2007) Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-non-Hodgkin’s lymphoma diagnosis. AIDS 21:2265–2270

    Article  PubMed  CAS  Google Scholar 

  45. Epeldegui M, Hung YP, McQuay A, Ambinder RF, Martinez-Maza O (2007) Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 44:934–942

    Article  PubMed  CAS  Google Scholar 

  46. Lenz G, Staudt LM (2010) Mechanisms of disease. Aggressive lymphomas. New Engl J Med 362:1417–1429

    Article  PubMed  CAS  Google Scholar 

  47. Gong JZ, Stenzel TT, Bennett ER, Lagoo AS, Dunphy CH, Moore JO, Rizzieri DA, Tepperberg JH, Papenhausen P, Buckley PJ (2003) Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases. Am J Surg Pathol 27:818–827

    Article  PubMed  Google Scholar 

  48. Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E (2003) Post-transplant Burkitt’s leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial). Leuk Lymphoma 44:1541–1543

    Article  PubMed  Google Scholar 

  49. Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104:3009–3020

    Article  PubMed  CAS  Google Scholar 

  50. Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H, Franchini G, Gutierrez M, Raffeld M, Jaffe ES, Shearer G, Yarchoan R, Wilson WH (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101:4653–4659

    Article  PubMed  CAS  Google Scholar 

  51. Spina M, Tirelli U, Zagonel V, Gloghini A, Volpe R, Babare R, Abbruzzese L, Talamini R, Vaccher E, Carbone A (1998) Burkitt lymphoma in adults with and without human immunodeficiency virus infection: a single institution clinicopathologic study of 75 patients. Cancer 82:766–774

    Article  PubMed  CAS  Google Scholar 

  52. Levine AM, Sullivan-Hailey J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, Wilson E, Brynes R, Parker J, Rasheed S (1991) Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 68:2466–2472

    Article  PubMed  CAS  Google Scholar 

  53. Chintu C, Athale UH, Patil PS (1995) Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child 73:100–105

    Article  PubMed  CAS  Google Scholar 

  54. Chitsike I, Siziya S (1998) Seroprevalence of human immunodeficiency virus type I infection in childhood malignancy in Zimbabwe. Cent Afr J Med 44:242–245

    PubMed  CAS  Google Scholar 

  55. Lazzi S, Ferrari F, Nyongo A, Palummo N, de Milito A, Zazzi M, Leoncini L, Luzi P, Tosi P (1998) HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 29:1285–1289

    Article  PubMed  CAS  Google Scholar 

  56. Lucas SB, Diomande M, Hounnou A, Beaumel A, Giordano C, Kadio A, Peacock CS, Honde M, De Cock KM (1994) HIV associated-lymphoma in Africa: an autopsy study in Cote d’Ivoire. Int J Cancer 59:20–24

    Article  PubMed  CAS  Google Scholar 

  57. Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katongole-Mbidde E, Wabinga H, Ziegler J (2000) Non-Hodgkin lymphoma in Uganda: a case–control study. AIDS 14:2929–2936

    Article  PubMed  CAS  Google Scholar 

  58. Lubega J (2007) T-helper 1 versus T-helper 2 lymphocyte immunodysregulation is the central factor in the genesis of Burkitt lymphoma: hypothesis. Infect Agent Cancer 2:10. doi:10.1186/1750-9378-2-10, Available from: http://www.infectagentcancer.com

    Article  PubMed  Google Scholar 

  59. Burmeister T, Schwartz S, Horst HA, Rieder H, Gökbuget N, Hoelzer D, Thiel E (2005) Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features. Leukemia 19:1391–1398

    Article  PubMed  CAS  Google Scholar 

  60. Yarchoan R, Uldrick TS, Little RF (2011) AIDS-associated lymphomas. In: Cancer: principles and practice of oncology, 9th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 2099–2112

    Google Scholar 

  61. Scadden D (2000) Epstein-Barr virus, the CNS, and AIDS-related lymphomas: as close as flame to smoke. J Clin Oncol 18:3323–3324

    PubMed  CAS  Google Scholar 

  62. Cingolani A, Gastaldi R, Fassone L, Pierconti F, Giancola ML, Martini M, De Luca A, Ammassari A, Mazzone C, Pescarmona E, Gaidano G, Larocca LM, Antinori A (2000) Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin’s lymphomas. J Clin Oncol 18:3325–3330

    PubMed  CAS  Google Scholar 

  63. Orem J, Maganda A, Katongole-Mbidde E, Weiderpass E (2009) Clinical characteristics and outcome of children with Burkitt’s lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer 52:455–458

    Article  PubMed  Google Scholar 

  64. Bateganya MH, Stanaway J, Brentlinger PE, Magaret AS, Wald A, Orem J, Casper C (2011) Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited ­setting: a retrospective study on the impact of HIV infection and its treatment. J Acquir Immune Defic Syndr 56:312–319

    Article  PubMed  Google Scholar 

  65. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1979) Report of the Committee on Hodgkin’s disease staging classification. Cancer Res 49:2112–2135

    Google Scholar 

  66. Mwanda WO, Orem J, Fu P, Banura C, Kakembo J, Onyango CA, Ness A, Reynolds S, Johnson JL, Subbiah V, Bako J, Wabinga H, Abdallah FK, Meyerson H, Whalen CC, Lederman MM, Black J, Ayers LW, Katongole-Mbidde E, Remick SC (2009) Dose-modified oral combination chemotherapy in the treatment of AIDS-related non-Hodgkin’s lymphoma in East Africa. J Clin Oncol 27:3480–3488

    Article  PubMed  CAS  Google Scholar 

  67. Krown S (2011) Cancer in resource-limited settings. J Acquir Immune Defic Syndr 56:297–299

    Article  PubMed  Google Scholar 

  68. Burkitt D, Hutt MSR, Wright DH (1965) The African lymphoma. Preliminary observations on response to chemotherapy. Cancer 18:399–410

    Article  PubMed  CAS  Google Scholar 

  69. Burkitt D (1967) Long-term remissions following one and two-dose chemotherapy for African lymphoma. Cancer 20:756–759

    Article  PubMed  CAS  Google Scholar 

  70. Ziegler JL, Magrath IT, Olweny CL (1979) Cure of Burkitt’s lymphoma. Ten-year follow-up of 157 Ugandan patients. Lancet 2:936–938

    Article  PubMed  CAS  Google Scholar 

  71. Olweny CLM, Katongole-Mbidde E, Otim D, Lwanga SK, Magrath IT, Ziegler JL (1980) Long term experience with Burkitt’s lymphoma in Uganda. Int J Cancer 26:261–266

    Article  PubMed  CAS  Google Scholar 

  72. Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Bick N, Kadin ME, Kieldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL (2003) Burkitt’s and Burkitt-like lymphoma in children and adolescents: a review of the Children’s Cancer Group experience. Br J Haematol 120:660–670

    Article  PubMed  Google Scholar 

  73. Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, Link M, Head D, Carroll A, Berard C, Murphy S (1996) Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small non-cleaved-cell lymphoma: a Pediatric Oncology Group study. J Clin Oncol 14:1252–1261

    PubMed  CAS  Google Scholar 

  74. Magrath I, Adde M, Shad A, Venzon D, Seibel D, Gootenberg J, Neely J, Arndt C, Nieder M, Jaffe E, Wittes RA, Horak ID (1996) Adults and children with small non-cleaved-cell lymphoma have similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925–934

    PubMed  CAS  Google Scholar 

  75. Lacasce A, Howard O, Lib S, Fisher D, Weng A, Neuberg D, Shipp M (2004) Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma 45:761–767

    Article  PubMed  CAS  Google Scholar 

  76. Fayad L, Thomas D, Romaquera J (2007) Update of the M.D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas. Clin Lymphoma Myeloma 8(Suppl 2):S57–S62

    Article  PubMed  CAS  Google Scholar 

  77. Stebbing J, Marvin V, Bower M (2004) The evidence-based treatment of AIDS-related non-Hodgkin’s lymphoma. Cancer Treat Rev 30:249–253

    Article  PubMed  Google Scholar 

  78. Lim ST, Levine AM (2005) Recent advances in the acquired immunodeficiency syndrome (AIDS)-related lymphoma. CA Cancer J Clin 55:229–241, 260–261, 264

    Article  PubMed  Google Scholar 

  79. Mounier N, Spina M, Gisselbrecht C (2007) Modern management of non-Hodgkin’s lymphoma in HIV-infected patients. Br J Haematol 136:685–698

    Article  PubMed  CAS  Google Scholar 

  80. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, Herndier B, Northfelt DW, Huang J, Tulpule A, Levine AM, for the NIAID Clinical Trials Group (1997) New Engl J Med 336:1641–1648

    Article  PubMed  CAS  Google Scholar 

  81. Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, Scadden D, Kaplan L, Ambinder R, Levine A, Harrington W, Grochow L, Flexner C, Tan B, Straus D, for the AIDS Malignancy Consortium (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19:2171–2178

    PubMed  CAS  Google Scholar 

  82. Sparano JA, Lee S, Chen MG, Nazeer T, Einzig A, Ambinder RF, Henry DH, Manalo J, Li T, Von Roenn JH (2004) Phase II trial of infusional cyclophosamide, doxorubicin, and etoposide in patients with human immunodeficiency virus-associated non-Hodgkin’s lymphoma: an Eastern Cooperative Oncology Group trial (E1494). J Clin Oncol 22:1491–1500

    Article  PubMed  CAS  Google Scholar 

  83. Kaplan LD, Lee JY, Ambinder RJ, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT (2005) Rituximab does not improve clinical outcome in a randomized phase III trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin’s lymphoma. Blood 106:1538–1543

    Article  PubMed  CAS  Google Scholar 

  84. Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R, for the AIDS Malignancy Consortium (2010) Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin’s lymphoma. Blood 115:3008–3016

    Article  PubMed  CAS  Google Scholar 

  85. Galicier L, Fieschi C, Borie R, Meignin V, Daniel MT, Gerard L, Oksenhendler E (2007) Intensive chemotherapy regimen (LMB86) for St. Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood 110:2846–2854

    Article  PubMed  CAS  Google Scholar 

  86. Noy A, Kaplan L, Lee J, Cesarman E, Tam W (2011) Modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression (2011). Presented at the 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies, 7–8 November 2011, Bethesda, MD, p 38 (abstract nos. 014)

    Google Scholar 

  87. Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D, Connor M, Bull D, Newton R, Beral V (2000) The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 88:489–492

    Article  PubMed  CAS  Google Scholar 

  88. Sissolak G, Abayomi EA, Jacobs P (2007) AIDS defining lymphomas in the era of highly active antiretroviral therapy (HAART) – an African perspective. Transfus Apher Sci 37:63–70

    Article  PubMed  Google Scholar 

  89. Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, LeMabec T, Forstin M-A, Renaudier P, N’Dom P, Malvy D, Dabis F (2010) The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One 5(e8621):1–10

    Google Scholar 

  90. Sissolak G, Juritz J, Sissolak D, Wood L, Jacobs P (2010) Lymphoma – emerging realities in sub-Saharan Africa. Transfus Apher Sci 42:141–150

    Article  PubMed  Google Scholar 

  91. Hesseling PB, Molyneux E, Tchinsterne F, Welbeck J, McCormick P, Pritchard-Jones K, Wagner H-P (2008) Treating Burkitt’s lymphoma in Malawi, Cameroon, and Ghana. Lancet Oncol 9:512–513

    Article  PubMed  Google Scholar 

  92. Hesseling PB, Broadhead R, Molyneux E, Borgstein E, Schneider JW, Louw M, Mansvelt EPG, Wessels G (2003) Malawi pilot study of Burkitt lymphoma treatment. Med Pediatr Oncol 41:532–540

    Article  PubMed  Google Scholar 

  93. Hesseling P, Broadhead R, Mansvelt E, Louw M, Wessels G, Borgstein E, Schneider J, Molyneux E (2005) The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer 44:245–250

    Article  PubMed  Google Scholar 

  94. Orem J, Mwanda WO, Remick SC (2006) Challenges and opportunities for treatment and research of AIDS-related malignancies in Africa. Curr Opin Oncol 18:479–486

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Haematology and Blood Transfusion, Department of Human Pathology, University of Nairobi College of Health Sciences, Nairobi, Kenya

    Peter M. Mwamba

  2. Laurence and Jean DeLynn Chair of Oncology, Mary Babb Randolph Cancer Center, West Virginia University, School of Medicine, Morgantown, WV, USA

    Scot C. Remick

Authors
  1. Peter M. Mwamba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scot C. Remick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scot C. Remick .

Editor information

Editors and Affiliations

  1. Perelman School of Medicine, University of Pennsylvania, Hamilton Walk 3610, Philadelphia, 19104, Pennsylvania, USA

    Erle S. Robertson

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer New York

About this chapter

Cite this chapter

Mwamba, P.M., Remick, S.C. (2013). AIDS-Associated Burkitt’s Lymphoma. In: Robertson, E. (eds) Burkitt’s Lymphoma. Current Cancer Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4313-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4313-1_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4312-4

  • Online ISBN: 978-1-4614-4313-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation